"Outcomes of COVID-19 infection in patients with hematological malignancies- A multicenter analysis from Pakistan".

ABSTRACT:

Purpose

COVID-19 infection resulting from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began to spread across the globe in early 2020. Patients with hematologic malignancies are supposed to have an increased risk of mortality from coronavirus disease of 2019 (COVID-19) infection. From Pakistan, we report the analysis of the outcome and interaction between patient demographics and tumor subtype and COVID-19 infection and hematological malignancy.

Patients and methods

This multicenter, retrospective study included adult patients with a history of histologically proven hematological malignancies who were tested positive for COVID-19 via PCR presented at the oncology department of 5 tertiary care hospitals in Pakistan from February to August 2020. A patient with

SUBMITTER: Zaki A 

PROVIDER: S-EPMC9022796 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature